Acute Kidney Injury (AKI): Clinical Trials

20 trials for Acute Kidney Injury (AKI), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 6 recruiting, 2 active not recruiting, 2 not yet recruiting. 4 Not applicable, 3 Phase 2, 2 Phase 3, 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable4Recruiting 2, Completed 1, Not yet recruiting 1
Phase 23Completed 1, Not yet recruiting 1, Terminated 1
Phase 32Recruiting 1, Terminated 1
Phase 42Recruiting 2
Phase 11Completed 1

Follow Acute Kidney Injury (AKI): new trials by email Literature Review of Acute Kidney Injury (AKI) trials Research Report on Acute Kidney Injury (AKI)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Precision-Medicine Diagnostic Support in Hospitalized Veterans With Acute Kidney Injury
PRECISE-AKI Clinical Decision Support Tool - Acute Kidney Injury (AKI)
Not applicableNot yet recruitingVA Office of Research and Development602028-01-012025-10-16
COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI)
AKI Discharge Summary Template, Chat-Based Educational Messaging Program - Acute Kidney Injury, Acute Kidney Injury (AKI)
Not applicableRecruitingNorthwell Health1602026-06-242026-10-20
The Impact of Blood Pressure Variability During the Induction and Surgical Periods on Postoperative Acute Kidney Injury
Acute Kidney Injury (AKI)
Active not recruitingZhongda Hospital50002026-06-012026-09-10
Trimethoprim-Sulfamethoxazole (TMP/SMX) Prophylaxis After Acute Kidney Injury to Prevent Post-discharge Infections
Drug: Trimethoprim-Sulfamethoxazole (TMP/SMX) 160/800 mg tablets every 48 hours, Placebo - Acute Kidney Injuries, Acute Kidney Disease
Phase 2Not yet recruitingHospital Civil de Guadalajara1202025-12-012025-11-05
Hamburg Acute Kidney Injury Study (HAKIS)
Acute Kidney Injury, Acute Kidney Injury (AKI)
RecruitingUniversitätsklinikum Hamburg-Eppendorf10002025-09-162026-10-01
AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney Disease
AST-120 (Kremezin®) - Acute Kidney Disease, Acute Kidney Injury (AKI)
Phase 4RecruitingChang Gung Memorial Hospital1002025-09-152025-09-19
NIRS Monitoring in the NICU and AKI
NIRS Monitoring - Acute Kidney Injury (AKI), Postnatal AKI
Not applicableRecruitingNYU Langone Health1002025-06-242026-10-22
Occurrence of Acute Kidney Injury After CAR-T Cells Treatments in B-cell Lymphoma.
Incidence of acute kidney injury, Describe risk factors in AKI occurrence., Focus on patient with chronic kidney disease at baseline - Acute Kidney Injury (AKI), Infusion of CD19 CAR T Cell
Active not recruitingHospices Civils de Lyon3002025-04-012025-08-03
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
Norepinephrine, Phenylephrine - Anesthesia, Surgery With General Anesthesia
Phase 4RecruitingUniversity of California, San Francisco180002025-04-012026-05-26
Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry
Prismaflex HF20 - Acute Renal Failure (ARF), Acute Kidney Injury (AKI)
CompletedVantive Health LLC592024-12-112026-02-17
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
Prismocitrate 18, PrisMax System Version 3.x with calcium line accessory - Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT)
Phase 3RecruitingVantive Health LLC402024-07-122026-10-05
Impact of Comprehensive Rehabilitation Nursing Combined With Refined Airway Management and Nutritional Support on Prognosis and Care Delivery Models in Critically Ill Patients
Standard Critical Care Nursing Protocol, ICU-PRO Nursing Protocol (Integrated Critical Care Protocol for Rehabilitation Outcomes) - Critically Ill Patients, Nutritional Support
Not applicableCompletedTaizhou Hospital of Traditional Chinese Medicine1012023-06-022025-06-18
Mitochondrial Health and Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients
Acute Kidney Injury (AKI)
UnknownOttawa Hospital Research Institute602021-12-062022-09-29
Effect of Cardiovascular Autonomic Neuropathy on AKI and Outcomes in Isolated CABG Surgery
Acute Kidney Injury (AKI), Coronary Artery Bypass Graft (CABG)
CompletedAkdeniz University9122021-11-042026-04-13
A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery
RMC-035, Placebo - Acute Kidney Injury (AKI)
Phase 1CompletedGuard Therapeutics AB132021-03-162024-04-23
Observational Study to Evaluate the Epidemiology of Surgical-induced Acute Kidney Injury
Acute Kidney Injury (AKI)
CompletedUniversity Hospital Muenster105682020-06-092022-07-21
Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery
ASP1128, Placebo - Acute Kidney Injury (AKI)
Phase 2CompletedAstellas Pharma Inc3512019-11-012024-12-04
Acute Kidney Injury as a Risk Factor for Myocardial Injury After Non Cardiac Surgery
Kidney function test - Acute Kidney Injury (AKI)
CompletedSouth Egypt Cancer Institute2402019-03-012021-10-05
Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants
Fenoldopam, 0.9%NS - Patent Ductus Arteriosus (PDA), Acute Kidney Injury (AKI)
Phase 2 / Phase 3TerminatedMedical College of Wisconsin12019-02-062022-09-16
Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury After Cardiac Surgery in Adults Study
CPB Surgery - Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD)
CompletedThe Royal Wolverhampton Hospitals NHS Trust4052016-05-012025-01-15

Narrower conditions

Acute Kidney Injury (20)  ·  Ductus Arteriosus, Patent (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Kidney Failure, Chronic (1)  ·  Lymphoma, B-Cell (1)  ·  Renal Insufficiency, Chronic (1)  ·  Wounds and Injuries (1)

Broader conditions

Female Urogenital Diseases (20)  ·  Female Urogenital Diseases and Pregnancy Complications (20)  ·  Kidney Diseases (20)  ·  Male Urogenital Diseases (20)  ·  Renal Insufficiency (20)  ·  Urogenital Diseases (20)  ·  Urologic Diseases (20)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Chronic Disease (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)

Interventions

ASP1128 (1)  ·  AST 120 (1)  ·  Fenoldopam (1)  ·  Injections (1)  ·  Kidney Function Tests (1)  ·  Norepinephrine (1)  ·  Phenylephrine (1)  ·  Saline Solution (1)  ·  Solutions (1)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (1)

Sponsors

Vantive Health LLC (2)  ·  Akdeniz University (1)  ·  Astellas Pharma Inc (1)  ·  Chang Gung Memorial Hospital (1)  ·  Guard Therapeutics AB (1)  ·  Hospices Civils de Lyon (1)  ·  Hospital Civil de Guadalajara (1)  ·  Medical College of Wisconsin (1)  ·  NYU Langone Health (1)  ·  Northwell Health (1)  ·  Ottawa Hospital Research Institute (1)  ·  South Egypt Cancer Institute (1)  ·  Taizhou Hospital of Traditional Chinese Medicine (1)  ·  The Royal Wolverhampton Hospitals NHS Trust (1)  ·  University Hospital Muenster (1)

Countries

United States (9)  ·  Germany (3)  ·  Canada (2)  ·  China (2)  ·  Egypt (2)  ·  France (2)  ·  Turkey (Türkiye) (2)  ·  Italy (1)  ·  Libya (1)  ·  Malta (1)  ·  North Macedonia (1)  ·  Palestinian Territories (1)  ·  Russia (1)  ·  Saudi Arabia (1)  ·  Slovenia (1)

Top investigators

Alexander Zarbock, MD, PhD (1)  ·  Allison Janda, MD (1)  ·  Douglas Colquhoun, MB ChB, MSc, MPH (1)  ·  Edward D Siew, MD MSc (1)  ·  Jeffrey Segar, MD (1)  ·  Jia Hwei Ng, MD, MSCE (1)  ·  Matthieu Legrand, MD PhD (1)  ·  Michael E Matheny, MD MS MPH (1)  ·  Michael P Bokoch, MD PhD (1)  ·  Rousseau Gama (1)  ·  Sachin Kheterpal, MD MBA (1)  ·  Sourabh Verma, MD (1)  ·  Tobias Agervald, MD PhD (1)  ·  Tobias B Huber, MD (1)

Results publications

PMID 35588372, PMID 37505258, PMID 38285051, PMID 39607014, PMID 41701325

NIH funding

K23DK132459 (1), R01DK139484 (1)